Nuvectis, Haisco ink up to $1.4B deal for two late-stage programs
Nuvectis Pharmaceuticals signed a deal worth up to $1.4B with Haisco Pharmaceutical for two late-stage oncology programs.
Nuvectis Pharma
Profile of Nuvectis Pharma created from news harvest. To be enriched by user.
Company Info
Sector:Precision Oncology / Small Molecule
Headquarters:Fort Lee, New Jersey, USA
Founded:2020
Website:nuvectis.com/
Clinical Development Pipeline
Undisclosed
Target: TBDRecent News
Leadership Team
Ron Bentsur
Chairman and Chief Executive Officer
Careers & Job Openings
No active job listings. Check back later.